-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Siremadlin Succinate in Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Siremadlin Succinate in Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Siremadlin Succinate in Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ILB-2102
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry ILB-2102 Drug Details ILB-2102 is under development for the treatment of autoimmune diseases. Report...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – BLSM-22
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry BLSM-22 Drug Details BLSM-22 (BLS-ILB-MD1) is under development for the treatment of Duchenne muscular...